ZIOPHARM ONCOLOGY INC Insider Trading for January 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ZIOPHARM ONCOLOGY INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ZIOPHARM ONCOLOGY INC for January 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Shukla Sath | EVP, Chief Financia ... | Option Exercise | A | 4.21 | 123,900 | 521,619 | 123,900 | |
| Jan 31 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Shukla Sath | EVP, Chief Financia ... | Grant | A | 0.00 | 80,500 | 0 | 80,500 | 0 to 80.5 K |
| Jan 31 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | MAUNEY DAVID M MD | President | Option Exercise | A | 4.21 | 123,900 | 521,619 | 123,900 | |
| Jan 31 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | MAUNEY DAVID M MD | President | Grant | A | 0.00 | 80,500 | 0 | 275,778 | 195.3 K to 275.8 K (+41.22 %) |
| Jan 31 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Lafond Kevin G | SVP, Treasurer & CA ... | Grant | A | 0.00 | 18,000 | 0 | 81,985 | 64 K to 82 K (+28.13 %) |
| Jan 31 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Hadfield Robert | General Counsel and ... | Option Exercise | A | 4.21 | 90,800 | 382,268 | 90,800 | |
| Jan 31 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Hadfield Robert | General Counsel and ... | Grant | A | 0.00 | 59,100 | 0 | 159,819 | 100.7 K to 159.8 K (+58.68 %) |
| Jan 31 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | De Groot Eleanor | EVP, GM Cell Therap ... | Option Exercise | A | 4.21 | 82,600 | 347,746 | 82,600 | |
| Jan 31 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | De Groot Eleanor | EVP, GM Cell Therap ... | Grant | A | 0.00 | 53,700 | 0 | 228,033 | 174.3 K to 228 K (+30.80 %) |
| Jan 31 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Cooper Laurence James Neil | Chief Executive Off ... | Option Exercise | A | 4.21 | 264,200 | 1,112,282 | 264,200 | |
| Jan 31 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Cooper Laurence James Neil | Chief Executive Off ... | Grant | A | 0.00 | 171,700 | 0 | 1,904,973 | 1.7 M to 1.9 M (+9.91 %) |
| Jan 31 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Buck Jill | EVP, GM Gene Therap ... | Option Exercise | A | 4.21 | 82,600 | 347,746 | 82,600 | |
| Jan 31 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Buck Jill | EVP, GM Gene Therap ... | Grant | A | 0.00 | 53,700 | 0 | 227,410 | 173.7 K to 227.4 K (+30.91 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Tarriff Scott | Director | Option Exercise | A | 4.72 | 50,562 | 238,653 | 50,562 | |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Pagan Douglas W. | Director | Option Exercise | A | 4.72 | 25,281 | 119,326 | 25,281 | |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Pagan Douglas W. | Director | Payment of Exercise | F | 4.72 | 20,054 | 94,655 | 35,943 | 56 K to 35.9 K (-35.81 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Pagan Douglas W. | Director | Grant | A | 0.00 | 15,890 | 0 | 55,997 | 40.1 K to 56 K (+39.62 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | MAUNEY DAVID M MD | President | Sell | S | 4.55 | 22,394 | 101,893 | 195,278 | 217.7 K to 195.3 K (-10.29 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Lafond Kevin G | SVP, Treasurer & CA ... | Option Exercise | A | 4.72 | 48,000 | 226,560 | 48,000 | |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Lafond Kevin G | SVP, Treasurer & CA ... | Sell | S | 4.55 | 21,570 | 98,144 | 63,985 | 85.6 K to 64 K (-25.21 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Hagen Heidi | Director | Grant | A | 0.00 | 31,780 | 0 | 32,119 | 339 to 32.1 K (+9,374.63 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Hadfield Robert | General Counsel and ... | Sell | S | 4.55 | 16,853 | 76,681 | 100,719 | 117.6 K to 100.7 K (-14.33 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Ezickson Elan | Director | Payment of Exercise | F | 4.72 | 40,107 | 189,305 | 71,887 | 112 K to 71.9 K (-35.81 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Ezickson Elan | Director | Grant | A | 0.00 | 31,780 | 0 | 111,994 | 80.2 K to 112 K (+39.62 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | De Groot Eleanor | EVP, GM Cell Therap ... | Sell | S | 4.55 | 24,890 | 113,250 | 174,333 | 199.2 K to 174.3 K (-12.49 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Buck Jill | EVP, GM Gene Therap ... | Sell | S | 4.55 | 27,923 | 127,050 | 173,710 | 201.6 K to 173.7 K (-13.85 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Braunstein Scott | Director | Grant | A | 0.00 | 31,780 | 0 | 31,780 | 0 to 31.8 K |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Bowden Christopher | Director | Option Exercise | A | 4.72 | 50,562 | 238,653 | 50,562 |